1. Home
  2. CNVS vs MIRA Comparison

CNVS vs MIRA Comparison

Compare CNVS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.42

Market Cap

65.5M

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$1.12

Market Cap

53.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNVS
MIRA
Founded
2000
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.5M
53.2M
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
CNVS
MIRA
Price
$2.42
$1.12
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
321.0K
126.9K
Earning Date
02-17-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
108.99
20.31
EPS
N/A
N/A
Revenue
$78,181,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$84.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.13
N/A
52 Week Low
$1.77
$0.81
52 Week High
$7.39
$2.45

Technical Indicators

Market Signals
Indicator
CNVS
MIRA
Relative Strength Index (RSI) 41.20 35.46
Support Level $2.37 N/A
Resistance Level $3.47 $1.35
Average True Range (ATR) 0.23 0.08
MACD -0.09 -0.00
Stochastic Oscillator 1.26 8.33

Price Performance

Historical Comparison
CNVS
MIRA

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: